Orthopedics
News, opinions and meeting coverage in orthopedics.
Medtronic's Infuse Moves From Operating Room to Courtroom
An investigative series by app/Milwaukee Journal Sentinel has been tracking the spinal fusion device called Infuse in a 4-year-long series and now reports how a flawed FDA system for device approval may have led to a long string of adverse events culminating in thousands of liability suits.
May 18, 2014
Spine Fusion Device Ignites Academic Feud
Responding to a series of studies linking Medtronic's bone morphogenetic protein-2 product to a number of serious adverse events, a leading BMP-2 researcher is taking the offensive by taking aim at his critics in a manner that some observers say goes too far. This latest report in an ongoing Milwaukee Journal Sentinel/app series details the claims and counterclaims.
Jul 07, 2011
Researcher Sounded Alarm on Medtronic's Infuse Years Ago
As part of a continuing investigation into a bone morphogenetic protein-2 product marketed as Infuse, the Milwaukee Journal Sentinel/app describe a first-hand account of early signs of problems with the device as well as efforts to minimize the clinical significance of those problems.
Jun 28, 2011